Asset Management One
AERI

Asset Management One’s Aerie Pharmaceuticals AERI Stock Holding History

Asset Management One’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,901
Closed -$223K – 1058
2016
Q4 		$223K Sell
5,901
-1,906
-24% -$72.1K ﹤0.01% 909
2016
Q3 		$294K Buy
+7,807
New +$172K ﹤0.01% 1166
2015
Q2 		– Sell
-149,714
Closed -$4.68M – 1396
2015
Q1 		$4.68M Buy
149,714
+32,287
+27% +$936K 0.06% 417
2014
Q4 		$3.53M Buy
+117,427
New +$2.98M 0.05% 515

Other funds holding AERI

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Asset Management One's AERI Position: Q1 2017 in Review

Asset Management One sold out of Aerie Pharmaceuticals (AERI) in Q1 2017, closing a stake of 5,901 shares — an estimated $223K sold.

Asset Management One first reported a position in AERI in Q4 2014 and held it in 4 quarters. The position peaked at $4.68M in Q1 2015. 159 funds tracked by Wall St. Rank hold AERI as of Q1 2017.

  • Asset Management One reported no remaining Aerie Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Asset Management One sold 5,901 Aerie Pharmaceuticals shares in Q1 2017, an estimated $223K.
  • Asset Management One first reported a position in Aerie Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Asset Management One's Aerie Pharmaceuticals position peaked at $4.68M in Q1 2015.
  • 159 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2017.

Based on Asset Management One's 13F filing for Q1 2017, filed 11 May 2017.